[Pharmacological and biochemical approach to a syndrome of action and intention myoclonus in the course of degenerative disease of the nervous system].
D006916:5-Hydroxytryptophan / Q000134:cerebrospinal fluid; D000328:Adult; D001552:Benzazepines; D002524:Cerebellar Ataxia / Q000175:diagnosis; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D003984:Dibenzazepines; D004295:Dihydroxyphenylalanine; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D004569:Electroencephalography; D004827:Epilepsy / Q000378:metabolism / Q000503:physiopathology*; D005621:Friedreich Ataxia / Q000175:diagnosis; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007659:Ketones; D008297:Male; D008750:Methyldopa; D008784:Methysergide; D009207:Myoclonus / Q000378:metabolism / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000378:metabolism; D009574:Nitro Compounds; D011736:Pyridoxine; D012701:Serotonin / Q000134:cerebrospinal fluid; D009435:Synaptic Transmission; D014149:Tranquilizing Agents
D001552:Benzazepines; D003984:Dibenzazepines; D007659:Ketones; D018377:Neurotransmitter Agents; D009574:Nitro Compounds; D014149:Tranquilizing Agents; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D004299:Dopamine beta-Hydroxylase; D011736:Pyridoxine; D008784:Methysergide
Approche pharmacologique et biochimique d'un syndrome de myoclonies d'action et d'intention au cours d'une affection dégénérative du système nerveux